Peptide Initiative

Peptides · Peptide comparison

Myristoyl Pentapeptide-17 vs Palmitoyl Pentapeptide-4 (Matrixyl)

Keratin-stimulating lipopeptide specifically designed to enhance eyelash and eyebrow growth through hair follicle activation.

Collagen-boosting signal peptide clinically proven to reduce wrinkles and fine lines in photoaged skin.

  • Cosmetic
  • Cosmetic

At a glance

Quick comparison

Dose rangeMyristoyl Pentapeptide-170.001–0.1 %Palmitoyl Pentapeptide-4 (Matrixyl)0.012–0.012 %
FrequencyMyristoyl Pentapeptide-17Once dailyPalmitoyl Pentapeptide-4 (Matrixyl)Once daily
AdministrationMyristoyl Pentapeptide-17TopicalPalmitoyl Pentapeptide-4 (Matrixyl)Topical
Cycle lengthMyristoyl Pentapeptide-17Ongoing/indefinitePalmitoyl Pentapeptide-4 (Matrixyl)Ongoing/indefinite
Onset speedMyristoyl Pentapeptide-17Moderate (1-2 weeks)Palmitoyl Pentapeptide-4 (Matrixyl)Moderate (1-2 weeks)
Evidence levelMyristoyl Pentapeptide-17Limited human trialsPalmitoyl Pentapeptide-4 (Matrixyl)Limited human trials

Efficacy

Benefit ratings

Eyelash Growth

Myristoyl Pentapeptide-1785%
Palmitoyl Pentapeptide-4 (Matrixyl)No recorded rating

Hair Strengthening

Myristoyl Pentapeptide-1780%
Palmitoyl Pentapeptide-4 (Matrixyl)No recorded rating

Safety Profile

Myristoyl Pentapeptide-1795%
Palmitoyl Pentapeptide-4 (Matrixyl)No recorded rating

Anti-Wrinkle

Myristoyl Pentapeptide-17No recorded rating
Palmitoyl Pentapeptide-4 (Matrixyl)82%

Collagen Production

Myristoyl Pentapeptide-17No recorded rating
Palmitoyl Pentapeptide-4 (Matrixyl)88%

Skin Rejuvenation

Myristoyl Pentapeptide-17No recorded rating
Palmitoyl Pentapeptide-4 (Matrixyl)80%

Technical data

Compound specifications

Myristoyl Pentapeptide-17

Molecular formula
C41H81N9O6
Molecular weight
796.2 Da
Half-life
Topical application; sustained follicular activity with daily reapplication
Bioavailability
Enhanced follicular penetration via myristic acid (C14) lipid conjugation
CAS number
959610-30-1

Palmitoyl Pentapeptide-4 (Matrixyl)

Molecular formula
C39H75N7O10
Molecular weight
802.1 Da
Half-life
Approximately 20-30 minutes in skin (rapidly degraded by aminopeptidases; palmitoylation improves stability vs unmodified KTTKS)
Bioavailability
Topical penetration through stratum corneum to dermis; detected at 4.2 µg/cm² in SC, 2.8 µg/cm² in epidermis, 0.3 µg/cm² in dermis
CAS number
214047-00-4

Protocols

Dosing compared

Myristoyl Pentapeptide-17

Topical

  • 0.001-0.1% in finished serum (supplied as a 0.1% / 1000 ppm active solution)Once or twice daily to lash line / brows · 8-16 weeks for visible lash effectCosmetic lash/brow active applied to the lash line; typical eye-area use concentrations and the 1000 ppm supplier solution define the formulation dose [6]. Topical only; not dosed systemically.

Palmitoyl Pentapeptide-4 (Matrixyl)

Topical

  • 3 ppm (0.0003%) active peptideTwice daily · 12 weeksThe dose with proven clinical results: a randomized controlled trial (n=93) showed visible improvement in photoaged facial skin at 3 ppm of active Pal-KTTKS applied twice daily over 12 weeks [1]. This is the active-peptide concentration, not the trade solution.
  • Up to 0.012% in finished productTwice daily · OngoingTypical concentration range found in commercial leave-on anti-aging products, considered safe for cosmetic use by industry review [6]. Higher than the minimum clinical dose but well within the safety-assessed range.

Applications

Best suited for

Myristoyl Pentapeptide-17

Individuals seeking longer, fuller eyelashes without prostaglandin-based prescriptions
Myristoyl Pentapeptide-17 is particularly well-suited for individuals focused on individuals seeking longer, fuller eyelashes without prostaglandin-based prescriptions. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Those with naturally thin or sparse eyebrows wanting natural enhancement
Myristoyl Pentapeptide-17 is particularly well-suited for individuals focused on those with naturally thin or sparse eyebrows wanting natural enhancement. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
People recovering from lash or brow loss due to extensions, aging, or over-plucking
Myristoyl Pentapeptide-17 is particularly well-suited for individuals focused on people recovering from lash or brow loss due to extensions, aging, or over-plucking. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Users wanting a gentle peptide-based alternative to bimatoprost (Latisse)
Myristoyl Pentapeptide-17 is particularly well-suited for individuals focused on users wanting a gentle peptide-based alternative to bimatoprost (latisse). Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Palmitoyl Pentapeptide-4 (Matrixyl)

Individuals seeking non-invasive anti-wrinkle treatment
Palmitoyl Pentapeptide-4 (Matrixyl) is particularly well-suited for individuals focused on individuals seeking non-invasive anti-wrinkle treatment. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [1].
Those with photoaged skin showing fine lines and loss of firmness
Palmitoyl Pentapeptide-4 (Matrixyl) is particularly well-suited for individuals focused on those with photoaged skin showing fine lines and loss of firmness. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [1].
People looking to boost collagen production through topical skincare
Palmitoyl Pentapeptide-4 (Matrixyl) is particularly well-suited for individuals focused on people looking to boost collagen production through topical skincare. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [1][2].
Sensitive skin types seeking well-tolerated anti-aging actives
Palmitoyl Pentapeptide-4 (Matrixyl) is particularly well-suited for individuals focused on sensitive skin types seeking well-tolerated anti-aging actives. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Safety profile

Side effects

Myristoyl Pentapeptide-17

Common

  • Mild Tingling at Lash Line
  • Temporary Eyelid Dryness
  • Product Residue Buildup
  • Lash Shedding During Initial Phase

Uncommon

  • Periorbital Sensitivity

Serious

  • Allergic Contact Reaction
  • Lipid Peroxidation and Oxidative Stress

Palmitoyl Pentapeptide-4 (Matrixyl)

Common

  • Mild Tingling
  • Transient Redness
  • Dryness with Exfoliants
  • Mild Irritation

Uncommon

  • Contact Dermatitis

Serious

  • Excessive Collagen Synthesis and Scar Risk

Research status

Safety & evidence

Myristoyl Pentapeptide-17

Evidence level
Limited human trials
FDA status
Research compound
Safety overview
Myristoyl pentapeptide-17 demonstrates excellent cosmetic safety with GRAS/safe-for-use status in topical formulations up to 3% concentration. No serious adverse events in 10+ years of cosmetic industry application; mild skin irritation rare (<1%) at recommended concentrations. Dermal penetration limited to epidermis; no systemic absorption in vitro. Well-tolerated in combination with other anti-aging ingredients; photostability adequate for cosmetic formulations.

Contraindications

  • Known hypersensitivity to myristoylated peptides or formulation components
  • Active eye infections, styes, or periorbital dermatitis
  • Post-surgical eye conditions where topical application is contraindicated
  • Concurrent use of prescription eyelash growth products without medical guidance

Palmitoyl Pentapeptide-4 (Matrixyl)

Evidence level
Limited human trials
FDA status
Research compound
Safety overview
Palmitoyl pentapeptide-4 (Matrixyl) was well tolerated by the skin in a 12-week controlled trial [1] and has been used in anti-aging skincare for 20+ years with no serious adverse events reported. Skin irritation potential is minimal at recommended 2-3% concentrations (irritation index <0.5). No systemic absorption via intact skin; confined to epidermis/dermis per Franz diffusion cell studies. Stability in formulations verified through HPLC analysis.

Contraindications

  • Known hypersensitivity to palmitoyl pentapeptide-4 or formulation excipients
  • Active skin infections at the application site
  • Severely compromised skin barrier with open wounds
  • No known systemic contraindications at cosmetic concentrations

Decision guide

Which is right for you?

Myristoyl Pentapeptide-17

Choose Myristoyl Pentapeptide-17 if…

  • Individuals seeking longer, fuller eyelashes without prostaglandin-based prescriptions
  • Those with naturally thin or sparse eyebrows wanting natural enhancement
  • People recovering from lash or brow loss due to extensions, aging, or over-plucking
  • Users wanting a gentle peptide-based alternative to bimatoprost (Latisse)

Palmitoyl Pentapeptide-4 (Matrixyl)

Choose Palmitoyl Pentapeptide-4 (Matrixyl) if…

  • Individuals seeking non-invasive anti-wrinkle treatment
  • Those with photoaged skin showing fine lines and loss of firmness
  • People looking to boost collagen production through topical skincare
  • Sensitive skin types seeking well-tolerated anti-aging actives